2006
DOI: 10.1074/mcp.m600222-mcp200
|View full text |Cite
|
Sign up to set email alerts
|

PEPPeR, a Platform for Experimental Proteomic Pattern Recognition

Abstract: Quantitative proteomics holds considerable promise for elucidation of basic biology and for clinical biomarker discovery. However, it has been difficult to fulfill this promise due to over-reliance on identification-based quantitative methods and problems associated with chromatographic separation reproducibility. Here we describe new algorithms termed "Landmark Matching" and "Peak Matching" that greatly reduce these problems. Landmark Matching performs time base-independent propagation of peptide identities o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
147
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 134 publications
(147 citation statements)
references
References 42 publications
0
147
0
Order By: Relevance
“…The workflow described here contains functionality similar to traditional AMT 5 and also PEPPeR, 8 but msInspect/AMT was designed to provide a highly flexible approach to combining data from different experimental and biological sources. For example, our AMT matching procedures described above were designed to function when only a potentially small number of peptide locations from an LC-MS experiment are present in the AMT database, such as may be the case when interrogating across dissimilar biospecimen types.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The workflow described here contains functionality similar to traditional AMT 5 and also PEPPeR, 8 but msInspect/AMT was designed to provide a highly flexible approach to combining data from different experimental and biological sources. For example, our AMT matching procedures described above were designed to function when only a potentially small number of peptide locations from an LC-MS experiment are present in the AMT database, such as may be the case when interrogating across dissimilar biospecimen types.…”
Section: Discussionmentioning
confidence: 99%
“…7 More recently, novel commercial instrumentation such as the LTQ-FT and Orbitrap, and the Q-TOF, have allowed simultaneous acquisition of both high-resolution LC-MS and LC-MS/MS data in a single experiment. Jaffe et al recently described a workflow incorporated in PEPPeR (Platform for Experimental Proteomic Pattern Recognition) 8 that combines peptide locations with amino acid sequences acquired from a series of related runs with these platforms. This workflow is related to the classic AMT approach in that it combines LC-MS and LC-MS/MS data, but because it takes advantage of embedded MS/MS data, it is useful for combining data across a series of related experiments and does not involve the use of externally derived data sources.…”
Section: Introductionmentioning
confidence: 99%
“…To quantify the sensitivity of the COFRADIC methodology, i.e., the ability to detect low-abundant as well as high-abundant peptide peaks, we used the dynamic range expressed in decibels (dB), which was calculated as: 10 log 10 P max P min (8) with P max and P min denoting the maximum and minimum peptide abundance measured in an experiment, obtained via Eqn (5). A dynamic range of 37 dB was found for all COFRADIC replicates.…”
Section: Human Blood Samplementioning
confidence: 99%
“…First, available software packages, such as, e.g., SpecArray, [3] PEPPeR, [5] and SuperHirn, [6] which can be used to analyze, combine, and interpret data from high-dimensional LC and MS as an automated procedure, are based on datadriven methods or image processing methods to extract the peptide features from LC-MS. We present an approach that does not operate on the LC-MS image and we argue that the prior processing of LC-MS data can be split into two parts. In the first part, the MS-scans are processed separately, in order to extract peptide features on the basis of prior biological knowledge about the peptide's isotopic distribution, and not on a data-driven method.…”
Section: Introductionmentioning
confidence: 99%
“…In general, these computational methods can be divided into two groups. In the first group, spectral features (typically isotopic clusters indicating a peptide) are detected first and then statistically compared [25][26][27][28][29]. Alternatively, the second group applies statistics first so that only differential features are detected from the extracted ion chromatograms [30][31][32][33].…”
Section: Differential Ms Quantitationmentioning
confidence: 99%